These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2814743)

  • 21. Sulpiride: evaluation of antipsychotic activity in schizophrenic patients.
    Mielke DH; Gallant DM; Roniger JJ; Kessler C; Kessler LR
    Dis Nerv Syst; 1977 Jul; 38(7):569-71. PubMed ID: 326504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic and side effects of treatment with sulpiride].
    Goldwurm GF; Peghini R
    Agressologie; 1978; 19(C):157-64. PubMed ID: 375762
    [No Abstract]   [Full Text] [Related]  

  • 24. Sulpiride versus chlorpromazine and placebo in the treatment of restless mentally subnormal patients--a double-blind cross-over study.
    Väisänen K; Kainulainen P; Paavilainen MT; Viukari M
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):202-5. PubMed ID: 803431
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride.
    Angelopoulos P; Markopoulou M; Kyamidis K; Bobotas K
    Gen Hosp Psychiatry; 2008; 30(5):482-4. PubMed ID: 18774435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.
    Kreinin A; Epshtein S; Sheinkman A; Tell E
    Isr J Psychiatry Relat Sci; 2005; 42(1):61-3. PubMed ID: 16134408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-over comparison of the therapeutic effects of sulpiride and perphenazine in schizophrenic and schizoaffective psychoses.
    Svestka J; Rysánek R; Cesková E; Náhunek K
    Act Nerv Super (Praha); 1989 Apr; 31(1):35-6. PubMed ID: 2571220
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double blind method].
    Asada S; Ishimaru T; Kubo S; Kodama H; Masuda K
    Encephale; 1976; 2(1):73-83. PubMed ID: 770152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical evaluation of sulpiride].
    Nurowska K
    Psychiatr Pol; 1980; 14(1):37-42. PubMed ID: 6988858
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinico-pharmacological studies of sulpiride.
    Nishiura M
    Curr Ther Res Clin Exp; 1976 Aug; 20(2):164-72. PubMed ID: 821717
    [No Abstract]   [Full Text] [Related]  

  • 32. Quetiapine combined with amisulpride in schizophrenic patients with insufficient responses to quetiapine monotherapy.
    Englisch S; Enning F; Grosshans M; Marquardt L; Waltereit R; Zink M
    Clin Neuropharmacol; 2010; 33(5):227-9. PubMed ID: 20838213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation of the anti-autistic activity of sulpiride.
    Elizur A; Davidson S
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):578-84. PubMed ID: 810319
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical psychometric evaluation of the effects of fluanxol, oxipertine and chlorpromazine in chronic schizophrenia. Comparative study].
    Predescu V; Ciurezu T; Romila A; Pirée S; Vianu I; Ionescu G; Braslă N; Florescu D; David E; Roman I; Zelingher R; Ivana D; Bucurică C; Damian N
    Neurol Psihiatr Neurochir; 1969; 14(5):389-400. PubMed ID: 5380156
    [No Abstract]   [Full Text] [Related]  

  • 35. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
    Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
    Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients.
    Clark ML; Kaul PN
    Psychopharmacol Bull; 1975 Oct; 11(4):28-30. PubMed ID: 1105638
    [No Abstract]   [Full Text] [Related]  

  • 37. Sulpiride: an advance in neuroleptics?
    Drug Ther Bull; 1984 Apr; 22(8):31-2. PubMed ID: 6143652
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of low vs. high doses of levosulpiride on negative symptoms of schizophrenia.
    Catapano F; Maj M; Grimaldi F; Ventra C; Kemali D
    Pharmacopsychiatry; 1992 May; 25(3):166. PubMed ID: 1635937
    [No Abstract]   [Full Text] [Related]  

  • 39. Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships.
    Clark ML; Ramsey HR; Rahhal DK; Serafetinides EA; Wood FD; Costiloe JP
    Arch Gen Psychiatry; 1972 Oct; 27(4):479-83. PubMed ID: 5072717
    [No Abstract]   [Full Text] [Related]  

  • 40. Amisulpride-induced tardive dyskinesia in childhood onset schizophrenia.
    Goyal N; Sinha VK
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):728-9. PubMed ID: 20347912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.